Keyphrases
Hereditary Angioedema
100%
Asthma
83%
Angioedema Attack
30%
C1 Inhibitor
22%
Lanadelumab
19%
Older Adults
19%
Allergen
16%
Placebo
16%
Angioedema
16%
Asthma Morbidity
14%
C1 Esterase Inhibitor
13%
United States
13%
World Trade Center
12%
Asthmatic
12%
Asthma Control
12%
C1 Inhibitor Deficiency
12%
Prophylactic Treatment
11%
Asthma Symptoms
11%
Allergic Asthma
10%
Older Patients
10%
Airway
9%
Posttraumatic Stress Disorder
9%
Ovalbumin
9%
Airway Inflammation
9%
Cockroach
9%
Long-term Prophylaxis
9%
German Cockroach
8%
Anti-asthma
8%
Hereditary Angioedema with Normal C1 Inhibitor
8%
Placebo-controlled
8%
Aging Effect
8%
Cockroach Allergen
8%
Epitope
8%
Aging
8%
Aged Mice
8%
Prophylaxis Treatment
8%
On-demand Treatment
7%
Odds Ratio
7%
Plasma Kallikrein
7%
Asthma in the Elderly
7%
Casein
7%
Health-related Quality of Life
7%
Gene Expression
7%
Attack Rate
7%
T Cell Response
7%
Herbal Medicine
7%
Young Patients
6%
Inner City
6%
Allergen Sensitization
6%
Emergency Department
6%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
96%
Asthma
51%
Complement Component C1s Inhibitor
40%
Placebo
19%
Lanadelumab
17%
Disease
14%
Isoniazid
13%
Adverse Event
12%
Ovalbumin
8%
Plasma Kallikrein
7%
Allergic Asthma
7%
Bradykinin
7%
Respiratory Tract Inflammation
5%
Immunoglobulin E
5%
Lung Disease
5%
Respiratory Tract Allergy
5%
Medicine and Dentistry
Hereditary Angioedema
61%
Asthma
47%
Complement Component C1s Inhibitor
27%
Lanadelumab
9%
Angioedema
8%
Isoniazid
8%
Disease
8%
Prophylaxis
8%
Allergic Asthma
8%
Posttraumatic Stress Disorder
7%
Emergency Department
6%
Ovalbumin
6%
Placebo
6%
Quality of Life
6%
Silo-Filler's Disease
5%
Adverse Event
5%
Gene Expression
5%